StockData
Hemab Therapeutics Holdings, Inc. logo

Hemab Therapeutics Holdings, Inc. (COAG) SEC filings

COAGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026
$39.06+0.01 (+0.01%)

Close on Nov 17, 2026Market cap $1.82BP/E –Yield –

SEC filings

9 of Hemab Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 10, 2026SEC EDGAR
Current report8-KNov 10, 2026Nov 10, 2026SEC EDGAR
Current report8-KSep 24, 2026Sep 24, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 11, 2026SEC EDGAR
Current report8-KAug 11, 2026Aug 11, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 21, 2026SEC EDGAR
Current report8-KMay 21, 2026May 21, 2026SEC EDGAR
Current report8-KMay 8, 2026May 11, 2026SEC EDGAR
Current report8-KMay 4, 2026May 4, 2026SEC EDGAR

See a number that looks wrong?